Confirm Endpoints as a trusted biopharma news source more like this The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO says July 27, 2026 MapLights schizophrenia drug dampens once-daily hopes despite Phase 2 win July 27, 2026 AstraZeneca looks to AI to ease risk in late-stage trials, speed up filings July 27, 2026 ENDPOINTS CAREERS Scientist, Drug Discovery Data for AI/ML D
Compared with other non-insulin hypoglycemic drugs, it can not only effectively reduce blood glucose and glycosylated hemoglobin (HbA1c), but also protect cardiovascular system, nervous system and kidney function without causing hypoglycemia and weight gain
References Min T, Bain SC
Standard semaglutide titration The typical semaglutide protocol starts at 0.25mg weekly for the first four weeks
Early research has explored whether GLP-1 agonists might enhance outcomes in autoimmune disease
This is where things get interesting